Earlier this year, the Federal Trade Commission’s (FTC) posed a roadblock in the path of sequencing giant Illumina’s $7.1 billion proposed acquisition of Grail, a healthcare company focusing on early cancer detection, and importantly, a 2016 spin-out from the former. Right now, the European Commission (EC) is also investigating the soundness of this deal. The justification provided by […]

Cartesian Therapeutics is a clinical stage biotechnology company headquartered in Gaithersburg, MD. Although it has just 20 employees, the company performs all its preclinical and regulatory work and clinical operations in-house. A few years ago, Cartesian also built a GMP manufacturing facility from the ground up. That gives the company its own quality management system […]

Three patients continue to show improvements in BCVA 3 years post-treatment. Interim results from an ongoing phase 1/2a clinical study (NCT02286089) evaluating OpRegen support the treatment’s efficacy in patients with dry age-related macular degeneration (AMD) with geographic atrophy (GA). Investigators found that 83% (10/12) of a cohort of treated patients continued to exhibit stable or improved Best […]